Evidence map›Paper›PMID 35086537›Full record

ArticleBMC complementary medicine and therapies2022

HPLC-DAD phenolics analysis, α-glucosidase, α-amylase inhibitory, molecular docking and nutritional profiles of Persicaria hydropiper L.

Mater H Mahnashi, Yahya S Alqahtani, Bandar A Alyami, Ali O Alqarni, Sultan A Alqahl, Farhat Ullah, Abdul Sadiq, Alam Zeb, Mehreen Ghufran, Alexey Kuraev and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Advance Glycation End Products Inhibition byFood science & nutrition · 2024
    Article
  5. Article
  6. UPLC-ESI-QTOF-MS Profiling of Phenolic Compounds fromMolecules (Basel, Switzerland) · 2022
    Article
  7. Fertility regulatory potential ofSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Mater H MahnashiDepartment of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Kingdom of Saudi Arabia.
Yahya S AlqahtaniDepartment of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Kingdom of Saudi Arabia.
Bandar A AlyamiDepartment of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Kingdom of Saudi Arabia.
Ali O AlqarniDepartment of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Kingdom of Saudi Arabia.
Sultan A AlqahlAhad Almsarha Hospital, Ahad Almsarha, Jazan, Saudi Arabia.
Farhat UllahDepartment of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, Dir (L), KP, 18000, Pakistan.
Abdul SadiqDepartment of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, Dir (L), KP, 18000, Pakistan.
Alam ZebDepartment of Biochemistry, University of Malakand, Chakdara, Dir (L), KP, 18000, Pakistan.
Mehreen GhufranDepartment of Pathology, MTI Bacha Khan Medical College, Mardan, Pakistan.
Alexey KuraevK.G. Razumovsky Moscow State University of Technologies and Management (The First Cossack University), 73, Zemlyanoy Val St, Moscow, Russian Federation, 109004.
Asif NawazDepartment of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, Dir (L), KP, 18000, Pakistan.
Muhammad AyazDepartment of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, Dir (L), KP, 18000, Pakistan. ayazuop@gmail.com.ORCID https://orcid.org/0000-0002-4299-2445
University of Malakand · PKNajran University · SABacha Khan University · PKMoscow State University of Technologies and Management named after K.G. Razumovskiy · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNatural phenolic compounds and Phenolics-rich medicinal plants are also of great interest in the management of diabetes. The current study was aimed to analyze phenolics in P. hydropiepr L extracts via HPLC-DAD analysis and assess their anti-diabetic potentials using in-vitro and in-silico approaches.

methodsPlant crude methanolic extract (Ph.Cme) was evaluated for the presence of phenolic compounds using HPLC-DAD analysis. Subsequently, samples including crude (Ph.Cr), hexane (Ph.Hex), chloroform (Ph.Chf), ethyl acetate (Ph.EtAc), butanol (Ph.Bt), aqueous (Ph.Aq) and saponins (Ph.Sp) were tested for α-glucsidase and α-amylase inhibitory potentials and identified compounds were docked against these target enzymes using Molecular Operating Environment (MOE) software. Fractions were also analyzed for the nutritional contents and acute toxicity was performed in animals.

resultsIn HPLC-DAD analysis of Ph.Cme, 24 compounds were indentfied and quantified. Among these, Kaemferol-3-(p-coumaroyl-diglucoside)-7-glucoside (275.4 mg g

conclusionsPhytochemical studies revealed the presence of highly valuable phenolic compounds, which might be responsible for the anti-diabetic potentials of the plant samples.

Indexed as

alpha-Amylasesalpha-GlucosidasesAnimalsChromatography, High Pressure LiquidDiabetes MellitusGlycoside Hydrolase InhibitorsHumansHypoglycemic AgentsMolecular Docking SimulationPhenolsPhytochemicalsPlant ExtractsPolygonaceaeSaponinsalpha-Amylasesalpha-GlucosidasesGlycoside Hydrolase InhibitorsHypoglycemic AgentsPhenolsPhytochemicalsPlant ExtractsSaponinsDiabetesHPLC-DAD analysisMolecular dockingPhenolicsP. hydropiperSaponins

Identifiers

PMID35086537
PMCPMC8793238
OpenAlexW4210589681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.